Swiss National Bank’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
VPM
VCM
AC
Swiss National Bank's HRMY Position: Q1 2026 in Review
Swiss National Bank held its Harmony Biosciences (HRMY) position steady in Q1 2026 at 85,100 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1761.
Swiss National Bank first reported a position in HRMY in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.18M in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.
- Swiss National Bank held 85,100 shares of Harmony Biosciences worth $2.38M as of Q1 2026.
- Swiss National Bank left its Harmony Biosciences share count unchanged in Q1 2026.
- Harmony Biosciences made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1761 holding.
- Swiss National Bank first reported a position in Harmony Biosciences in Q2 2021 and has held it in 20 quarters since.
- Swiss National Bank's Harmony Biosciences position peaked at $3.18M in Q4 2025.
- 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.
Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.